(Q46099944)

English

Randomized, open-label study of the impact of two doses of subcutaneous recombinant interleukin-2 on viral burden in patients with HIV-1 infection and CD4+ cell counts of > or = 300/mm3: CPCRA 059.

scientific article published in March 2002

Statements

Randomized, open-label study of the impact of two doses of subcutaneous recombinant interleukin-2 on viral burden in patients with HIV-1 infection and CD4+ cell counts of > or = 300/mm3: CPCRA 059. (English)
Terry Beirn Community Programs for Clinical Research on AIDS

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit